AI Detection of Facial and Micro-Expressions in Mental and Neurological Diagnosis

Overview

This systematic review evaluates recent advances in artificial intelligence (AI) for detecting facial and micro-expressions to aid diagnosis of mental and neurological disorders. It highlights current algorithms, datasets, and challenges, emphasizing the gap between laboratory research and clinical application.

Background

Mental and neurological disorders such as depression, anxiety, schizophrenia, bipolar disorder, autism, Parkinson’s, and Alzheimer’s pose significant health and societal burdens. Traditional diagnostic methods rely heavily on clinical interviews and imaging, which are costly, time-consuming, and prone to subjective errors. AI-based facial and micro-expression analysis offers a promising alternative by enabling rapid, objective detection of subtle emotional cues linked to these disorders. However, challenges including data standardization, algorithm accuracy, and ethical considerations remain barriers to clinical translation.

Data Highlights

The review included studies published between 2021 and 2025 identified through multiple databases including PubMed, Scopus, and IEEE Xplore. Due to heterogeneity in methods and indicators, meta-analysis was not feasible. Key data points extracted involved types of AI algorithms used, datasets characteristics, and evaluation metrics, though specific numerical performance data were not uniformly reported.

Key Findings

• AI algorithms, especially deep learning models, show promise in detecting micro-expressions linked to mental and neurological disorders with improved accuracy over traditional methods.
• Most studies focus on limited disorders such as autism and depression, with fewer addressing a broader range of conditions.
• Datasets used are often small, homogeneous, and lack standardized protocols for collection and labeling, limiting generalizability.
• Environmental factors (lighting, camera angle), cultural differences, and voluntary facial expressions affect algorithm performance and diagnostic accuracy.
• Ethical, legal, and privacy concerns regarding facial data use remain insufficiently addressed in current research.
• There is a significant gap between laboratory research findings and real-world clinical application due to lack of standardized evaluation and validation in clinical settings.

Clinical Implications

Clinicians should be aware of the potential of AI-based facial expression analysis as a supplementary diagnostic tool, particularly for early detection of mental and neurological disorders. However, caution is warranted given current limitations in data diversity, algorithm robustness, and ethical safeguards. Integration into clinical practice requires standardized protocols and validation in diverse patient populations to ensure reliability and accuracy.

Conclusion

AI-driven analysis of facial and micro-expressions represents a promising frontier for enhancing diagnosis of mental and neurological disorders. Addressing existing methodological, ethical, and practical challenges is essential to translate these technologies from research to routine clinical use.

References

1. Systematic Review on AI and Facial Expression Analysis in Mental Health (2025)